https://stock.noler.com/us/stock/epizyme-inc https://stock.noler.com/us/stock/epizyme-inc/accounts-payable https://stock.noler.com/us/stock/epizyme-inc/accounts-receivable https://stock.noler.com/us/stock/epizyme-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/epizyme-inc/accrued-liabilities-current https://stock.noler.com/us/stock/epizyme-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/epizyme-inc/accrued-royalties-current https://stock.noler.com/us/stock/epizyme-inc/accumulated-depreciation https://stock.noler.com/us/stock/epizyme-inc/additional-paid-in-capital https://stock.noler.com/us/stock/epizyme-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/epizyme-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/epizyme-inc/amortization https://stock.noler.com/us/stock/epizyme-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/epizyme-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/epizyme-inc/aoci https://stock.noler.com/us/stock/epizyme-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/epizyme-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions-greater-than-or-equal-to-one-year https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-securities https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-aggregate-losses https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-unrealized-loss-position-less-than-12-months-aggregate-losses https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/epizyme-inc/available-for-sale-unrealized-loss-position-twelve-months-or-longer-fair-value https://stock.noler.com/us/stock/epizyme-inc/basic-shares https://stock.noler.com/us/stock/epizyme-inc/capital-expenditures https://stock.noler.com/us/stock/epizyme-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/epizyme-inc/capital-lease-obligations https://stock.noler.com/us/stock/epizyme-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/epizyme-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/epizyme-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/epizyme-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/epizyme-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/epizyme-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/epizyme-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/epizyme-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/epizyme-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/epizyme-inc/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/epizyme-inc/cash-and-equivalents https://stock.noler.com/us/stock/epizyme-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/epizyme-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/epizyme-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/epizyme-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/epizyme-inc/cash-flow-breakdown https://stock.noler.com/us/stock/epizyme-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/epizyme-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/epizyme-inc/common-stock-value https://stock.noler.com/us/stock/epizyme-inc/comprehensive-income https://stock.noler.com/us/stock/epizyme-inc/contract-liability https://stock.noler.com/us/stock/epizyme-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/epizyme-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/epizyme-inc/contractual-obligation https://stock.noler.com/us/stock/epizyme-inc/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/epizyme-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/epizyme-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/epizyme-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/epizyme-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/epizyme-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/epizyme-inc/cost-of-revenue https://stock.noler.com/us/stock/epizyme-inc/costs-and-expenses https://stock.noler.com/us/stock/epizyme-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/epizyme-inc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/epizyme-inc/current-assets https://stock.noler.com/us/stock/epizyme-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/epizyme-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/epizyme-inc/current-liabilities https://stock.noler.com/us/stock/epizyme-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/epizyme-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/epizyme-inc/debt-carrying-amount https://stock.noler.com/us/stock/epizyme-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/epizyme-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/epizyme-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/epizyme-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/epizyme-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/epizyme-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/epizyme-inc/debt-unamortized-discount https://stock.noler.com/us/stock/epizyme-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/epizyme-inc/deferred-revenue https://stock.noler.com/us/stock/epizyme-inc/deferred-revenue-2 https://stock.noler.com/us/stock/epizyme-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/epizyme-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/epizyme-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/epizyme-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/epizyme-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/epizyme-inc/depreciation https://stock.noler.com/us/stock/epizyme-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/epizyme-inc/diluted-shares https://stock.noler.com/us/stock/epizyme-inc/dilutive-shares https://stock.noler.com/us/stock/epizyme-inc/dividends-declared https://stock.noler.com/us/stock/epizyme-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/epizyme-inc/effective-tax-rate https://stock.noler.com/us/stock/epizyme-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/epizyme-inc/eps https://stock.noler.com/us/stock/epizyme-inc/eps-basic https://stock.noler.com/us/stock/epizyme-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/epizyme-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/epizyme-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/epizyme-inc/fifo-inventory-amount https://stock.noler.com/us/stock/epizyme-inc/financing-cash-flow https://stock.noler.com/us/stock/epizyme-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/epizyme-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/epizyme-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/epizyme-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/epizyme-inc/gain-loss-on-fair-value-hedges-recognized-in-earnings https://stock.noler.com/us/stock/epizyme-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/epizyme-inc/general-and-administrative-expense https://stock.noler.com/us/stock/epizyme-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/epizyme-inc/income-tax https://stock.noler.com/us/stock/epizyme-inc/income-tax-receivable https://stock.noler.com/us/stock/epizyme-inc/income-taxes-paid https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-contract-receivables-net https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-other-noncurrent-assets-and-liabilities-net https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/epizyme-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/epizyme-inc/insider-transactions-other https://stock.noler.com/us/stock/epizyme-inc/insider-transactions-preferred https://stock.noler.com/us/stock/epizyme-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/epizyme-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/epizyme-inc/insider-transactions-warrants https://stock.noler.com/us/stock/epizyme-inc/interest-income-expense-net https://stock.noler.com/us/stock/epizyme-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/epizyme-inc/interest-income-other https://stock.noler.com/us/stock/epizyme-inc/interest-paid https://stock.noler.com/us/stock/epizyme-inc/interest-paid-net https://stock.noler.com/us/stock/epizyme-inc/interest-receivable https://stock.noler.com/us/stock/epizyme-inc/inventory https://stock.noler.com/us/stock/epizyme-inc/inventory-noncurrent https://stock.noler.com/us/stock/epizyme-inc/investing-cash-flow https://stock.noler.com/us/stock/epizyme-inc/lease-cost https://stock.noler.com/us/stock/epizyme-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/epizyme-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/epizyme-inc/license-and-services-revenue https://stock.noler.com/us/stock/epizyme-inc/marketable-securities-current https://stock.noler.com/us/stock/epizyme-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/epizyme-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/epizyme-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/epizyme-inc/net-change-in-cash https://stock.noler.com/us/stock/epizyme-inc/net-income https://stock.noler.com/us/stock/epizyme-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/epizyme-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/epizyme-inc/number-of-reportable-segments https://stock.noler.com/us/stock/epizyme-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/epizyme-inc/operating-cash-flow https://stock.noler.com/us/stock/epizyme-inc/operating-income https://stock.noler.com/us/stock/epizyme-inc/operating-lease-assets https://stock.noler.com/us/stock/epizyme-inc/operating-lease-cost https://stock.noler.com/us/stock/epizyme-inc/operating-lease-liability https://stock.noler.com/us/stock/epizyme-inc/operating-lease-liability-current https://stock.noler.com/us/stock/epizyme-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-future-minimum-sublease-rentals https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/epizyme-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/epizyme-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/epizyme-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/epizyme-inc/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/epizyme-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/epizyme-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/epizyme-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/epizyme-inc/other-current-liabilities https://stock.noler.com/us/stock/epizyme-inc/other-expenses https://stock.noler.com/us/stock/epizyme-inc/other-income https://stock.noler.com/us/stock/epizyme-inc/other-noncurrent-assets https://stock.noler.com/us/stock/epizyme-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/epizyme-inc/other-nonoperating-expense https://stock.noler.com/us/stock/epizyme-inc/other-nonoperating-income https://stock.noler.com/us/stock/epizyme-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/epizyme-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/epizyme-inc/other-receivables https://stock.noler.com/us/stock/epizyme-inc/other-than-temporary-impairment-loss-debt-securities-available-for-sale https://stock.noler.com/us/stock/epizyme-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/epizyme-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/epizyme-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/epizyme-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/epizyme-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/epizyme-inc/payments-for-merger-related-costs https://stock.noler.com/us/stock/epizyme-inc/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/epizyme-inc/payments-for-rent https://stock.noler.com/us/stock/epizyme-inc/payments-for-restructuring https://stock.noler.com/us/stock/epizyme-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/epizyme-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/epizyme-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/epizyme-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/epizyme-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/epizyme-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/epizyme-inc/preferred-shares-facts https://stock.noler.com/us/stock/epizyme-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/epizyme-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/epizyme-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/epizyme-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/epizyme-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/epizyme-inc/preferred-stock-value https://stock.noler.com/us/stock/epizyme-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/epizyme-inc/pretax-income https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-insurance-settlement-investing-activities https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/epizyme-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/epizyme-inc/profit-loss https://stock.noler.com/us/stock/epizyme-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/epizyme-inc/property-plant-equipment https://stock.noler.com/us/stock/epizyme-inc/public-float https://stock.noler.com/us/stock/epizyme-inc/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/epizyme-inc/research-and-development https://stock.noler.com/us/stock/epizyme-inc/restricted-cash https://stock.noler.com/us/stock/epizyme-inc/restructuring-charges https://stock.noler.com/us/stock/epizyme-inc/restructuring-reserve https://stock.noler.com/us/stock/epizyme-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/epizyme-inc/restructuring-reserve-current https://stock.noler.com/us/stock/epizyme-inc/restructuring-reserve-noncurrent https://stock.noler.com/us/stock/epizyme-inc/retained-earnings https://stock.noler.com/us/stock/epizyme-inc/revenue https://stock.noler.com/us/stock/epizyme-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/epizyme-inc/security-deposit https://stock.noler.com/us/stock/epizyme-inc/sga-expense https://stock.noler.com/us/stock/epizyme-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/epizyme-inc/share-price https://stock.noler.com/us/stock/epizyme-inc/shareholders-equity https://stock.noler.com/us/stock/epizyme-inc/shares-authorized https://stock.noler.com/us/stock/epizyme-inc/shares-issued https://stock.noler.com/us/stock/epizyme-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/epizyme-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/epizyme-inc/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/epizyme-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/epizyme-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/epizyme-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/epizyme-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/epizyme-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/epizyme-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/epizyme-inc/stock-award-rsu-aggregate-intrinsic-value-vested https://stock.noler.com/us/stock/epizyme-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/epizyme-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/epizyme-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/epizyme-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/epizyme-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/epizyme-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/epizyme-inc/stock-based-compensation https://stock.noler.com/us/stock/epizyme-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/epizyme-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/epizyme-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/epizyme-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/epizyme-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/epizyme-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/epizyme-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/epizyme-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/epizyme-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/epizyme-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/epizyme-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/epizyme-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/epizyme-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/epizyme-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/epizyme-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/epizyme-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/epizyme-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/epizyme-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/epizyme-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/epizyme-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/epizyme-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/epizyme-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/epizyme-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/epizyme-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/epizyme-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/epizyme-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/epizyme-inc/stock-split-ratio https://stock.noler.com/us/stock/epizyme-inc/tax-cuts-and-jobs-act-income-tax-expense-benefit https://stock.noler.com/us/stock/epizyme-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/epizyme-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/epizyme-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/epizyme-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/epizyme-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/epizyme-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/epizyme-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-redemption-value https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/epizyme-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/epizyme-inc/total-assets https://stock.noler.com/us/stock/epizyme-inc/total-contract-liability https://stock.noler.com/us/stock/epizyme-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/epizyme-inc/total-long-term-debt https://stock.noler.com/us/stock/epizyme-inc/treasury-stock-retired-cost-method-amount https://stock.noler.com/us/stock/epizyme-inc/treasury-stock-shares https://stock.noler.com/us/stock/epizyme-inc/undistributed-earnings-allocated-to-participating-securities https://stock.noler.com/us/stock/epizyme-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/epizyme-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/epizyme-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/epizyme-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/epizyme-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/epizyme-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/epizyme-inc/variable-lease-cost https://stock.noler.com/us/stock/epizyme-inc/weighted-average-number-of-share-outstanding-basic-and-diluted